Skip to Main Content

Author Details

Janet Andersen
Harvard School of Public Health
1989
56
29
PMIDPaper TitleJournal TitlePublished Year
30865794One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis.N Engl J Med2019
29590326Safety and Immunogenicity of Zoster Vaccine Live in Human Immunodeficiency Virus-Infected Adults With CD4+ Cell Counts >200 Cells/mL Virologically Suppressed on Antiretroviral Therapy.Clin Infect Dis2018
27046707Drug-resistant tuberculosis clinical trials: proposed core research definitions in adults.Int J Tuberc Lung Dis2016
26082504Efavirenz Pharmacokinetics and Pharmacodynamics in HIV-Infected Persons Receiving Rifapentine and Isoniazid for Tuberculosis Prevention.Clin Infect Dis2015
24226057Tuberculosis immune reconstitution inflammatory syndrome in A5221 STRIDE: timing, severity, and implications for HIV-TB programs.J Acquir Immune Defic Syndr2014
25734172The effect of hepatitis C virologic clearance on cardiovascular disease biomarkers in human immunodeficiency virus/hepatitis C virus coinfection.Open Forum Infect Dis2014
24525470Pilot study of pioglitazone before HCV retreatment in HIV/HCV genotype 1-infected subjects with insulin resistance and previous nonresponse to peginterferon and ribavirin therapy: A5239.J Acquir Immune Defic Syndr2014
23485388Screening for pulmonary tuberculosis in HIV-infected individuals: AIDS Clinical Trials Group Protocol A5253.Int J Tuberc Lung Dis2013
23921611Hepatitis C virus/HIV coinfection and responses to initial antiretroviral treatment.AIDS2013
22563020Impact of peginterferon alpha and ribavirin treatment on lipid profiles and insulin resistance in Hepatitis C virus/HIV-coinfected persons: the AIDS Clinical Trials Group A5178 Study.Clin Infect Dis2012
23002445Elevated interleukin 8 and T-helper 1 and T-helper 17 cytokine levels prior to antiretroviral therapy in participants who developed immune reconstitution inflammatory syndrome during ACTG A5164.J Infect Dis2012
23043386Health-related quality of life in subjects with HCV/HIV coinfection: results from ACTG 5178 study.J Viral Hepat2012
22510354Extended therapy with pegylated interferon and weight-based ribavirin for HCV-HIV coinfected patients.HIV Clin Trials2012
21737585CDC/NIH Workshop. Tuberculosis biomarker and surrogate endpoint research roadmap.Am J Respir Crit Care Med2011
22010914Timing of antiretroviral therapy for HIV-1 infection and tuberculosis.N Engl J Med2011
21535051The incidence, predictors and management of anaemia and its association with virological response in HCVâ¿¿/â¿¿HIV coinfected persons treated with long-term pegylated interferon alfa 2a and ribavirin.Aliment Pharmacol Ther2011
21690628Blood (1->3)-beta-D-glucan as a diagnostic test for HIV-related Pneumocystis jirovecii pneumonia.Clin Infect Dis2011
20617176Risk factor analyses for immune reconstitution inflammatory syndrome in a randomized study of early vs. deferred ART during an opportunistic infection.PLoS One2010
20921898Sustained long-term antiviral maintenance therapy in HCV/HIV-coinfected patients (SLAM-C).J Acquir Immune Defic Syndr2010
20622678Women experience higher rates of adverse events during hepatitis C virus therapy in HIV infection: a meta-analysis.J Acquir Immune Defic Syndr2010
19268724Improving noninvasive methods of assessing liver fibrosis in patients with hepatitis C virus/human immunodeficiency virus co-infection.Clin Gastroenterol Hepatol2009
19632953Low rate of CMV end-organ disease in HIV-infected patients despite low CD4+ cell counts and CMV viremia: results of ACTG protocol A5030.HIV Clin Trials2009
19770624Short-term ezetimibe is well tolerated and effective in combination with statin therapy to treat elevated LDL cholesterol in HIV-infected patients.AIDS2009
19387354Prevalence and persistence of cervical human papillomavirus infection in HIV-positive women initiating highly active antiretroviral therapy.J Acquir Immune Defic Syndr2009
19440326Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial.PLoS One2009
18442305Prior illicit drug use and missed prenatal vitamins predict nonadherence to antiretroviral therapy in pregnancy: adherence analysis A5084.AIDS Patient Care STDS2008
17425430Dendritic cell-based vaccine strategy against human immunodeficiency virus clade C: skewing the immune response toward a helper T cell type 2 profile.Viral Immunol2007
17711380Attitudes and perceptions of AIDS clinical trials group site coordinators on HIV clinical trial recruitment and retention: a descriptive study.AIDS Patient Care STDS2007
17477814Viral factors associated with cytokine expression during HCV/HIV co-infection.J Interferon Cytokine Res2007
17403409Protease inhibitor-based antiretroviral therapy and glucose tolerance in pregnancy: AIDS Clinical Trials Group A5084.Am J Obstet Gynecol2007
17395549Factors associated with early study discontinuation in AACTG studies, DACS 200.Contemp Clin Trials2007
16672399Multilaboratory comparison of hepatitis C virus viral load assays.J Clin Microbiol2006
16991084Immunogenetics of CD4 lymphocyte count recovery during antiretroviral therapy: An AIDS Clinical Trials Group study.J Infect Dis2006
17058225Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127.Hepatology2006
16967041Predictors of antiretroviral-related hepatotoxicity in the adult AIDS Clinical Trial Group (1989-1999).J Acquir Immune Defic Syndr2006
16912957Pharmacogenetics of nevirapine-associated hepatotoxicity: an Adult AIDS Clinical Trials Group collaboration.Clin Infect Dis2006
16439867Relationships between cellular immune responses and treatment outcomes with interferon and ribavirin in HIV/hepatitis C virus co-infection.AIDS2006
16545621A reduced frequency visit schedule underreports adverse events that resulted in dose modifications or treatment discontinuations in HIV/AIDS clinical trials: ACTG DACS 207.Contemp Clin Trials2006
15867490Antigen-specific immune responses and liver histology in HIV and hepatitis C coinfection.AIDS2005
16131307Clinical, microbiological, and immunological characteristics in HIV-infected subjects at risk for disseminated Mycobacterium avium complex disease: an AACTG study.AIDS Res Hum Retroviruses2005
16192248The safety of discontinuation of maintenance therapy for cytomegalovirus (CMV) retinitis and incidence of immune recovery uveitis following potent antiretroviral therapy.HIV Clin Trials2005
15282352Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons.N Engl J Med2004
14583845A multi-investigator/institutional DNA bank for AIDS-related human genetic studies: AACTG Protocol A5128.HIV Clin Trials2003
12904347Comparison of molecular tests for detection and quantification of cell-associated cytomegalovirus DNA.J Clin Microbiol2003
11941551Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Recherche sur le SIDA, Essai 039.Clin Infect Dis2002
12218391A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS.AIDS2002
11978287Isotretinoin for low-grade cervical dysplasia in human immunodeficiency virus-infected women.Obstet Gynecol2002
11462019Postnatal passive immunization of neonatal macaques with a triple combination of human monoclonal antibodies against oral simian-human immunodeficiency virus challenge.J Virol2001
11283052Comparison of quantitative and qualitative PCR assays for cytomegalovirus DNA in plasma.J Clin Microbiol2001
11723375Clinical trials in neuro-oncology.Curr Opin Neurol2001
  • 1 - 50 of 56

Recommended Authors

Sara H Bares
University of Nebraska Medical Center
Career Start Year 2011
Number of shared co-authors 2
Sheila M Keating
University of California San Francisco
Career Start Year 2002
Number of shared co-authors 2
Timothy J Henrich
University of California san francisco
Career Start Year 2002
Number of shared co-authors 4
Davey M Smith
University of California San Diego
Career Start Year 2001
Number of shared co-authors 10
Sudhir Penugonda
Northwestern University Feinberg School of Medicine
Career Start Year 2000
Number of shared co-authors 1
Matthias Cavassini
Lausanne University Hospital, University of Lausanne
Career Start Year 1999
Number of shared co-authors 3
Susanna Naggie
Duke Clinical Research Institute and Duke University School of Medicine
Career Start Year 1998
Number of shared co-authors 8
Carlo Torti
&quotMagna Graecia&quot University
Career Start Year 1998
Number of shared co-authors 1
Laura Smeaton
Harvard TH Chan School of Public Health
Career Start Year 1996
Number of shared co-authors 11
Charles B Hare
Kaiser Permanente San Francisco Medical Center
Career Start Year 1994
Number of shared co-authors 2
Chloe L Thio
Johns Hopkins University
Career Start Year 1993
Number of shared co-authors 6
Sharon R Lewin
The University of Melbourne at the Peter Doherty Institute for Infection and Immunity
Career Start Year 1993
Number of shared co-authors 6
Roger Paredes
Hospital Germans Trias i Pujol
Career Start Year 1992
Number of shared co-authors 3
Kelly A Gebo
Johns Hopkins School of Medicine, Johns Hopkins University
Career Start Year 1990
Number of shared co-authors 9
Jos?? R Arribas
La Paz University Hospital
Career Start Year 1988
Number of shared co-authors 3
Carl J Fichtenbaum
University of Cincinnati
Career Start Year 1988
Number of shared co-authors 10
Jason Flamm
Sacramento Medical Center, Kaiser Permanente Northern California
Career Start Year 1988
Number of shared co-authors 3
Steven G Deeks
University of California san francisco
Career Start Year 1988
Number of shared co-authors 12
Ian Frank
IF School of Medicine, University of Pennsylvania
Career Start Year 1987
Number of shared co-authors 11
Virginia L Kan
VA Medical Center
Career Start Year 1986
Number of shared co-authors 1
Richard T Davey
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1985
Number of shared co-authors 4
Ann C Collier
University of Washington
Career Start Year 1984
Number of shared co-authors 13
Stephen Raffanti
Vanderbilt University Medical Center
Career Start Year 1983
Number of shared co-authors 7
Henry Clifford Lane
Division of Clinical Research, National Institutes of Allergy and Infectious Diseases
Career Start Year 1981
Number of shared co-authors 3
Peter Bacchetti
University of California San Francisco
Career Start Year 1981
Number of shared co-authors 6
Barbara Gripshover
Case Western Reserve University
Career Start Year 1981
Number of shared co-authors 3
Bonaventura Clotet
IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol
Career Start Year 1979
Number of shared co-authors 6
John Allen McCutchan
University of California San Diego
Career Start Year 1975
Number of shared co-authors 8
Joseph B Margolick
Johns Hopkins Bloomberg School of Public Health
Career Start Year 1973
Number of shared co-authors 7
Luis J Montaner
Wistar Institute
Career Start Year 1958
Number of shared co-authors 4

Collaborators

Raymond T Chung
Massachusetts General Hospital and Harvard Medical School
Co-authored papers 14
Susan Swindells
University of Nebraska Medical Center
Co-authored papers 7
Ruth M Ruprecht
University of Texas San Antonio
Co-authored papers 5
Michael M Lederman
Co-authored papers 3
David W Haas
Vanderbilt University Medical Center
Co-authored papers 3
Judith S Currier
David Geffen School of Medicine, University of California los angeles
Co-authored papers 3
David A Wohl
The University of North Carolina School of Medicine
Co-authored papers 2
Gregory K Robbins
Co-authored papers 2
Grant R Wilkinson
1 Vanderbilt University Medical Center
Co-authored papers 2
David C Montefiori
Co-authored papers 2
Laura F Mahon
Co-authored papers 2
David B Clifford
Washington University School of Medicine
Co-authored papers 1
Gregory J Tsongalis
Dartmouth Health and the Dartmouth Cancer Center, USA Geisel School of Medicine
Co-authored papers 1
Kristine Coughlin
Frontier Science and Technology Research Foundation
Co-authored papers 1
Carol L Brosgart
University of California San Francisco
Co-authored papers 1
Paul E Sax
Co-authored papers 1
Jo Anne Bennett
New York University
Co-authored papers 1
Paul Volberding
Institute for Global Health Sciences, University of California san francisco
Co-authored papers 1
Louis J Picker
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Co-authored papers 1
Daniel R Kuritzkes
Brigham and Women's Hospital, Harvard Medical School
Co-authored papers 1
Jeffrey M Jacobson
Co-authored papers 1
Zachary Goodman
Center for Liver Diseases, Inova Fairfax Hospital
Co-authored papers 1
Douglas D Richman
Center for AIDS Research, University of California San Diego
Co-authored papers 1
Paul Succop
Co-authored papers 1
Dushyantha Jayaweera
University of Miami, Miller School of Medicine
Co-authored papers 1
Margaret A Matula
Co-authored papers 1
Jody Lawrence
Inc., Collegeville
Co-authored papers 1
Cara Sutcliffe
Vanderbilt University
Co-authored papers 1
Ann Marshak-Rothstein
University of Massachusetts School of Medicine
Co-authored papers 1
Michael S Saag
University of Alabama at Birmingham
Co-authored papers 1
Release 1.2